PHOENIX, Feb. 06, 2023 (GLOBE NEWSWIRE) -- #" Featured Image for ArmorPoint Featured Image for ArmorPoint

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer 18-01-2024, 11:05